Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study

BACKGROUND: Cholangiocarcinoma (CCA) is a highly heterogeneous malignant tumor, and more than 60% of patients have recurrence and metastasis after surgery. The efficacy of postoperative adjuvant therapy for CCA remains unclear. This study aimed to explore whether adjuvant therapy benefits patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhongquan, Han, Xin, You, Wanlu, Tang, Jinlong, Xu, Juehua, Ye, Binglin, Li, Tengfei, Zhang, Yixin, Chen, Kai, Ding, Yuan, Wang, Weilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063974/
https://www.ncbi.nlm.nih.gov/pubmed/37007129
http://dx.doi.org/10.3389/fonc.2023.1116338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063974/
https://www.ncbi.nlm.nih.gov/pubmed/37007129
http://dx.doi.org/10.3389/fonc.2023.1116338

Ejemplares similares